ELN484228-SDS-MedChemExpress.pdf
《ELN484228-SDS-MedChemExpress.pdf》由会员分享,可在线阅读,更多相关《ELN484228-SDS-MedChemExpress.pdf(6页珍藏版)》请在文库网上搜索。
1、GSK1059615Cat. No.: HY-12036CAS No.: 958852-01-2Molecular Formula: CHNOSMolecular Weight: 333.36Target: PI3K; mTORPathway: PI3K/Akt/mTORStorage: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 monthSolvent PI3K, IC50: 0.6 nM; PI3K, IC50: 5 nM; PI3K, IC50: 2 nM; mTOR, IC50: 12 nMIn Vitro
2、GSK1059615 inhibits PI3K, , and , with Ki of 0.42 nM, 0.6 nM, 0.47 nM and 1.7 nM, respectively1. In T47D and BT474 cancer cells, GSK1059615 inhibits the phosphorylation of Akt at S473, with IC50 of 40 nM2.In Vivo GSK1059615 (25 mg/kg) effectively inhibits tumor growth in xenograft mice models of BT4
3、74 or HCC1954 breast cancer cells1.Product Data Sheet InhibitorsAgonistsScreening Librarieswww.MedChemE1PROTOCOLKinase Assay 2 The measurement of the GSK1059615-dependent inhibition of the PI3Ks is accessed using a HTRF based PI3K profiling assay kit. 400 pM enzyme is used in PI3K and assays, 200 pM
4、 in PI3K assays, and 1 nM in PI3K assay. In addition, the PI3K, , and assays are run with 150 mM NaCl and 100 M ATP, while the PI3K assay is run with no NaCl and 15 M ATP. All reactions are run at 10 M PIP2. GSK1059615 is serially diluted (3-fold in DMSO), and 50 nL is transferred to a 384-well low-
5、volume assay plate. PI3K Reaction Buffer is prepared by diluting the stock 1:4 with de-ionized water. Freshly prepared DTT is added at a final concentration of 5 mM on the day of use. Enzyme addition and GSK1059615 pre-incubation are initiated by the addition of 2.5 L of PI3K in reaction buffer. Pla
6、tes are incubated at room temperature for 15 min. Reactions are initiated by addition of 2.5 L of 2 substrate solution (PIP2 and ATP in 1 reaction buffer). Plates are incubated at room temperature for one hour. Reactions are quenched by the addition of 2.5 L of stop solution. The quenched reactions
7、are then processed to detect product formation by adding 2.5 L of Detection Solution. Following a 1-hour incubation in the dark, the HTRF signal is measured on the Envision plate reader set for 330 nm excitation and dual emission detection at 620 nm (Eu) and 665 nm (APC). The IC50 value is then obta
8、ined.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Cell Assay 2 Cells are plate at a density of 1104 cells per well in clear flat-bottomed 96-well plates and incubated overnight. Then, GSK1059615 is added and the plates are incubated for 30 min. At th
9、e end of incubation, media is aspirated from the plates, and the plate is wash once with cold PBS. 80 L MSD Lysis buffer is added into each well and the plates are incubated on a shaker at 4C for at least 30 min. For Akt duplex assay, plates are washed with 200 L/well wash buffer for 4 times and tap
10、ped on paper towel to blot. Then, 60 L lysates is added to each well and the plates are incubated on shaker at room temperature for 1 hour. After another 4 times washing, antibody is added (25 L per well) and the plates are incubated on shaker for 1 hour and washed again. Finally, Read Buffer is add
11、ed (150 L per well) and the plates are read immediately. IC50 values are then obtained.MCE has not independently confirmed the accuracy of these methods. They are for reference only.CUSTOMER VALIDATIONSee more customer validations on www.MedChemEREFERENCES1. Carnero A. Novel inhibitors of the PI3K f
12、amily. Expert Opin Investig Drugs. 2009 Sep;18(9):1265-77.2. Maira SM, et al. From the bench to the bed side: PI3K pathway inhibitors in clinical development. Curr Top Microbiol Immunol, 2010, 347, 209-239.3. Takashi Kei Kishimoto, et al. Methods and compositions for attenuating gene therapy anti-vi
13、ral transfer vector immune responses. US 20160074531 A1. Patent. US10046064B2. Patent. US20180193482A1. Patent. US20160074531A1. Patent. US20160074372A1. Patent. US20160074532A1.www.MedChemE2Caution: Product has not been fully validated for medical app Inhibitors, Agonists, Screening Librarieswww.Me
14、dChemESafety Data SheetRevision Date:Oct.-08-2018Print Date: Oct.-08-20181. PRODUCT AND COMPANY IDENTIFICATION1.1 Product identifierProduct name : GSK1059615Catalog No. : HY-12036CAS No. : 958852-01-21.2 Relevant identified uses of the substance or mixture and uses advised againstIdentified uses : L
15、aboratory chemicals, manufacture of substances.1.3 Details of the supplier of the safety data sheetCompany: MedChemExpress USATel: 609-228-6898Fax: 609-228-5909E-mail: 1.4 Emergency telephone numberEmergency Phone #: 609-228-68982. HAZARDS IDENTIFICATION2.1 Classification of the substance or mixture
16、GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)Acute toxicity, Oral (Category 4),H302Acute aquatic toxicity (Category 1),H400Chronic aquatic toxicity (Category 1),H4102.2 GHS Label elements, including precautionary statementsPictogramSignal word WarningHazard statement(s)H302 Harmful if
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- ELN484228 SDS MedChemExpress